MetaADEDB 2.0 @ LMMD
Therapy partial responder
(UMLS:C4285679)
UMLS ID:
C4285679
MeSH ID:
N/A
Synonym(s)
1.
Therapy partial responder
Associated Drug(s)
NameNumber of ReportsReference(s)Data Source
1difluprednateFAERS: 160US FAERS
2apremilastFAERS: 50US FAERS
3nepafenacFAERS: 26US FAERS
4rucaparibFAERS: 26US FAERS
5SimbrinzaFAERS: 25US FAERS
6TravoprostFAERS: 14US FAERS
7Ruxolitinib phosphateFAERS: 6US FAERS
8CarboplatinFAERS: 5US FAERS
9AfatinibFAERS: 4US FAERS
10Mycophenolic AcidFAERS: 4US FAERS
11ponatinibFAERS: 4US FAERS
12sapropterinFAERS: 4US FAERS
13Fingolimod HydrochlorideFAERS: 3US FAERS
14ceritinibFAERS: 3US FAERS
15osimertinibFAERS: 3US FAERS
16AMG-416FAERS: 2US FAERS
17CyclosporineFAERS: 2US FAERS
18HhAntag691FAERS: 2
Canada Vigilance: 2
Canada Vigilance
US FAERS
19Imatinib MesylateFAERS: 2US FAERS
20MechlorethamineFAERS: 2US FAERS
21OlanzapineFAERS: 2US FAERS
22PrednisoloneFAERS: 2US FAERS
23VoriconazoleFAERS: 2US FAERS
24glimepirideFAERS: 2US FAERS
25pazopanibFAERS: 2US FAERS
26pomalidomideFAERS: 2US FAERS
27tofacitinibFAERS: 2US FAERS
281-N'-[2-[[5-[(Dimethylamino)methyl]furan-2-yl]methylsulfanyl]ethyl]-1-N-methyl-2-nitroethene-1,1-diamine;hydron;chlorideFAERS: 1US FAERS
295-O-[1-[3,3-Diphenylpropyl(methyl)amino]-2-methylpropan-2-yl] 3-O-methyl 2,6-dimethyl-4-(3-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylate;hydron;chlorideFAERS: 1US FAERS
30BaclofenFAERS: 1US FAERS
31Bendamustine HydrochlorideFAERS: 1US FAERS
32ClozapineFAERS: 1US FAERS
33Deamino Arginine VasopressinFAERS: 1US FAERS
34DexlansoprazoleFAERS: 1US FAERS
35DoxorubicinFAERS: 1US FAERS
36Erlotinib HydrochlorideFAERS: 1US FAERS
37GabapentinFAERS: 1US FAERS
38GefitinibFAERS: 1US FAERS
39Imatinib MesylateFAERS: 1US FAERS
40LCZ 696FAERS: 1US FAERS
41LenalidomideFAERS: 1US FAERS
42LevetiracetamFAERS: 1US FAERS
43LoratadineFAERS: 1US FAERS
44MemantineFAERS: 1US FAERS
45NaproxenFAERS: 1
Canada Vigilance: 1
Canada Vigilance
US FAERS
46PCI 32765FAERS: 1US FAERS
47PemetrexedFAERS: 1US FAERS
48PrepopikFAERS: 1US FAERS
49Quetiapine FumarateFAERS: 1US FAERS
50RibavirinFAERS: 1US FAERS
51ThyroxineFAERS: 1US FAERS
52Vortioxetine hydrobromideFAERS: 1US FAERS
53argatrobanFAERS: 1US FAERS
54aripiprazole lauroxilFAERS: 1US FAERS
55brexpiprazoleFAERS: 1US FAERS
56carbidopa, levodopa drug combinationFAERS: 1US FAERS
57eltrombopagFAERS: 1US FAERS
58gemcitabineFAERS: 1US FAERS
59idelalisibFAERS: 1US FAERS
60levocetirizineFAERS: 1US FAERS
61midostaurinFAERS: 1US FAERS
62olaparibFAERS: 1US FAERS
63regorafenibFAERS: 1US FAERS
64Lisdexamfetamine DimesylateCanada Vigilance: 1Canada Vigilance
65TemozolomideCanada Vigilance: 1Canada Vigilance
Powered by :

Page last updated at 2020-05-25 10:01:57 (Asia/Shanghai) | You are visitor No. 120240

Copyright © 2019-2020 Laboratory of Molecular Modeling and Design, Shanghai Key Laboratory of New Drug Design, School of Pharmacy, East China University of Science and Technology. All rights reserved.